Correlation Between PDS Biotechnology and Scpharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Scpharmaceuticals, you can compare the effects of market volatilities on PDS Biotechnology and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Scpharmaceuticals.

Diversification Opportunities for PDS Biotechnology and Scpharmaceuticals

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between PDS and Scpharmaceuticals is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Scpharmaceuticals go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Scpharmaceuticals

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Scpharmaceuticals. In addition to that, PDS Biotechnology is 1.2 times more volatile than Scpharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest  553.00  in Scpharmaceuticals on September 4, 2024 and sell it today you would lose (193.00) from holding Scpharmaceuticals or give up 34.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Scpharmaceuticals

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

PDS Biotechnology and Scpharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Scpharmaceuticals

The main advantage of trading using opposite PDS Biotechnology and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.
The idea behind PDS Biotechnology Corp and Scpharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins